Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy.
Telemedicine in diabetes includes telemonitoring and transmission of important data (self monitoring of blood glucose data, insulin therapy, pump setting, etc.) from the patient s home to the diabetic unit, with a real-time health feedback. Moreover, an eHealth approach is thought to facilitate diabetes management and to improve compliance to CSII/SAP treatment in adolescents, but to date, limited literature related to this topic is available and long-term studies are still lacking. The main aim of this study was to compare the long-term effect on glycometabolic control of eHealth intervention and traditional care in T1DM SAP-treated adolescents. In our study we demonstrated a favorable impact of monthly teleassistance on treatment compliance. Adolescents receiving frequent feedback provided by the medicalmultidisciplinary team, due to the telemonitoring, resulted more compliant in self-management of diabetes. In particular, the medical team feedback resulted in interventions on behavioral errors and insulin therapy adjustments, leading to an improved glycometabolic control.
Unit of Endocrinology and Diabetes, Bambino Gesù Children's Hospital, Italy riccardo.schiaffini@opbg.net.
R
R
Schiaffini
Technology, HTA and Safety Research Unit, Bambino Gesù Children's Hospital, Italy.
I
I
Tagliente
Unit of Endocrinology and Diabetes, Bambino Gesù Children's Hospital, Italy.
C
C
Carducci
Department of Pediatric Medicine, Bambino Gesù Children's Hospital, Rome, Italy.
N
N
Ullmann
Unit of Endocrinology and Diabetes, Bambino Gesù Children's Hospital, Italy.
P
P
Ciampalini
Clinical Trial Center, Bambino Gesù Children's Hospital, Italy.
A
A
Lorubbio
Unit of Endocrinology and Diabetes, Bambino Gesù Children's Hospital, Italy.
M
M
Cappa
D000293:Adolescent; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D008297:Male; D018670:Monitoring, Ambulatory / Q000379:methods*; D010348:Patient Care Team / Q000458:organization & administration; D010349:Patient Compliance / Q000706:statistics & numerical data*; D010353:Patient Education as Topic / Q000458:organization & administration; D012648:Self Care; D017216:Telemedicine / Q000458:organization & administration*
D007004:Hypoglycemic Agents; D007328:Insulin
Telecare; eHealth; teleconsulting; telehealth; telemedicine